CERA

unofficial impact factor 1.46
Search for
Advanced search
Cost Effectiveness and Resource Allocation
Tools
Open Access Highly Access Email this article to a friend

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Nicolas M Furiak, Haya Ascher-Svanum*, Robert W Klein, Lee J Smolen, Anthony H Lawson, Robert R Conley and Steven D Culler

Cost Effectiveness and Resource Allocation 2009, 7:4 doi:10.1186/1478-7547-7-4

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.